|
Duspatalin retard
Mebeverin hydroclorid
- Strength / route
- 200mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Mylan Laboratories S.A.S (France)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-21652-19 |
200mg
Oral
|
Tablet |
0
|
5,870
|
0
|
N1 |
Mylan Laboratories S.A.S
France
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Duspatalin retard
Mebeverin hydroclorid
- Strength / route
- 200mg · Oral
- Qty
- 102,752 Tablet
- Total
- 603,154,240
- Group
- N1
- Manufacturer
- Mylan Laboratories S.A.S (France)
- Province / Facility
- Ho Chi Minh City · 79048
|
300110982124 |
200mg
Oral
|
Tablet |
102,752
|
5,870
|
603,154,240
|
N1 |
Mylan Laboratories S.A.S
France
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Ecipa 50
Aescin
- Strength / route
- 50mg · Oral
- Qty
- 90,000 Tablet
- Total
- 682,200,000
- Group
- N4
- Manufacturer
- Apimed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01816
|
VD-35724-22 |
50mg
Oral
|
Tablet |
90,000
|
7,580
|
682,200,000
|
N4 |
Apimed Pharmaceutical JSC
Vietnam
|
Hanoi
01816
|
2026-04-14 |
|
Eliquis
Apixaban
- Strength / route
- 2,5mg · Oral
- Qty
- 41,600 Tablet
- Total
- 1,004,640,000
- Group
- N1
- Manufacturer
- Manufacturing site: Pfizer Ireland Pharmaceuticals - Packaging and batch release site: Pfizer Manufacturing Deutschland GmbH (Manufacturing site: Ireland - Packaging and batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
539110436423 |
2,5mg
Oral
|
Tablet |
41,600
|
24,150
|
1,004,640,000
|
N1 |
Manufacturing site: Pfizer Ireland Pharmaceuticals - Packaging and batch release site: Pfizer Manufacturing Deutschland GmbH
Manufacturing site: Ireland - Packaging and batch release site: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Eliquis
Apixaban
- Strength / route
- 5mg · Oral
- Qty
- 32,058 Tablet
- Total
- 774,200,700
- Group
- N1
- Manufacturer
- Manufacturing site: Pfizer Ireland Pharmaceuticals - Packaging and batch release site: Pfizer Manufacturing Deutschland GmbH (Manufacturing site: Ireland - Packaging and batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
539110436323 |
5mg
Oral
|
Tablet |
32,058
|
24,150
|
774,200,700
|
N1 |
Manufacturing site: Pfizer Ireland Pharmaceuticals - Packaging and batch release site: Pfizer Manufacturing Deutschland GmbH
Manufacturing site: Ireland - Packaging and batch release site: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Eloxatin
Oxaliplatin
- Strength / route
- 100mg/20ml · Intravenous infusion
- Qty
- 650 Vial
- Total
- 3,213,320,500
- Group
- N1
- Manufacturer
- Sanofi-Aventis Deutschland GmbH (Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19902-16 |
100mg/20ml
Intravenous infusion
|
Vial |
650
|
4,943,570
|
3,213,320,500
|
N1 |
Sanofi-Aventis Deutschland GmbH
Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Eloxatin
Oxaliplatin
- Strength / route
- 50mg/10ml · Intravenous infusion
- Qty
- 390 Vial
- Total
- 1,159,773,420
- Group
- N1
- Manufacturer
- Sanofi-Aventis Deutschland GmbH (Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19903-16 |
50mg/10ml
Intravenous infusion
|
Vial |
390
|
2,973,778
|
1,159,773,420
|
N1 |
Sanofi-Aventis Deutschland GmbH
Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Eloxatin
Oxaliplatin
- Strength / route
- 100mg/ 20ml · Injection
- Qty
- 443 Vial
- Total
- 2,190,001,510
- Group
- N1
- Manufacturer
- Sanofi-Aventis Deutschland GmbH (Germany)
- Province / Facility
- Da Nang · 48126
|
VN-19902-16 |
100mg/ 20ml
Injection
|
Vial |
443
|
4,943,570
|
2,190,001,510
|
N1 |
Sanofi-Aventis Deutschland GmbH
Germany
|
Da Nang
48126
|
2026-04-14 |
|
Eloxatin
Oxaliplatin
- Strength / route
- 50mg/10ml · Injection
- Qty
- 148 Vial
- Total
- 440,119,144
- Group
- N1
- Manufacturer
- Sanofi-Aventis Deutschland GmbH (Germany)
- Province / Facility
- Da Nang · 48126
|
VN-19903-16 |
50mg/10ml
Injection
|
Vial |
148
|
2,973,778
|
440,119,144
|
N1 |
Sanofi-Aventis Deutschland GmbH
Germany
|
Da Nang
48126
|
2026-04-14 |
|
Elthon 50mg
Itoprid
- Strength / route
- 50mg · Oral
- Qty
- 455,000 Tablet
- Total
- 2,182,180,000
- Group
- N1
- Manufacturer
- Katsuyama Pharmaceuticals K.K., Katsuyama Plant. (Japan)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-18978-15 |
50mg
Oral
|
Tablet |
455,000
|
4,796
|
2,182,180,000
|
N1 |
Katsuyama Pharmaceuticals K.K., Katsuyama Plant.
Japan
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Endoxan
Cyclophosphamid
- Strength / route
- 500mg · Injection
- Qty
- 8,800 Vial
- Total
- 1,172,424,000
- Group
- N1
- Manufacturer
- Baxter Oncology GmbH (Germany)
- Province / Facility
- Ho Chi Minh City · 79428
|
VN-16582-13 |
500mg
Injection
|
Vial |
8,800
|
133,230
|
1,172,424,000
|
N1 |
Baxter Oncology GmbH
Germany
|
Ho Chi Minh City
79428
|
2026-04-14 |
|
Entecavir Stella 0.5mg
Entecavir
- Strength / route
- 0,5mg · Oral
- Qty
- 400,020 Tablet
- Total
- 6,360,318,000
- Group
- N3
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hai Duong · 30341
|
893114106923 |
0,5mg
Oral
|
Tablet |
400,020
|
15,900
|
6,360,318,000
|
N3 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hai Duong
30341
|
2026-04-14 |
|
Ephedrine Aguettant 30mg/10ml
Ephedrin (hydroclorid)
- Strength / route
- 30mg/10ml · Injection
- Qty
- 511 Ampoule
- Total
- 44,533,650
- Group
- N1
- Manufacturer
- Laboratoire Aguettant (France)
- Province / Facility
- Da Nang · 48126
|
300113029623 |
30mg/10ml
Injection
|
Ampoule |
511
|
87,150
|
44,533,650
|
N1 |
Laboratoire Aguettant
France
|
Da Nang
48126
|
2026-04-14 |
|
Ephedrine Aguettant 30mg/ml
Ephedrin
- Strength / route
- 30mg/ml · Injection
- Qty
- 5,000 Ampoule
- Total
- 288,750,000
- Group
- N1
- Manufacturer
- Laboratoire Aguettant (France)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-19221-15 |
30mg/ml
Injection
|
Ampoule |
5,000
|
57,750
|
288,750,000
|
N1 |
Laboratoire Aguettant
France
|
Thua Thien Hue
46001
|
2026-04-14 |
|
Ephedrine Aguettant 30mg/ml
Ephedrin (hydroclorid)
- Strength / route
- 30mg/ml · Injection
- Qty
- 400 Ampoule
- Total
- 23,100,000
- Group
- N1
- Manufacturer
- LABORATOIRE AGUETTANT (France)
- Province / Facility
- Nghe An · 40018
|
VN-19221-15 |
30mg/ml
Injection
|
Ampoule |
400
|
57,750
|
23,100,000
|
N1 |
LABORATOIRE AGUETTANT
France
|
Nghe An
40018
|
2026-04-14 |
|
Epilona DR
Valproat natri
- Strength / route
- 200mg · Oral
- Qty
- 1,724 Tablet
- Total
- 2,637,720
- Group
- N4
- Manufacturer
- Hera Biopharmaceutical Co., Ltd. (Vietnam)
- Province / Facility
- Da Nang · 48126
|
893114258724 |
200mg
Oral
|
Tablet |
1,724
|
1,530
|
2,637,720
|
N4 |
Hera Biopharmaceutical Co., Ltd.
Vietnam
|
Da Nang
48126
|
2026-04-14 |
|
Eraxis
Anidulafungin
- Strength / route
- 100mg · Intravenous infusion
- Qty
- 2,399 Vial
- Total
- 9,189,129,600
- Group
- N1
- Manufacturer
- Pharmacia & Upjohn Company LLC (United States)
- Province / Facility
- Ho Chi Minh City · 79048
|
001110024425 |
100mg
Intravenous infusion
|
Vial |
2,399
|
3,830,400
|
9,189,129,600
|
N1 |
Pharmacia & Upjohn Company LLC
United States
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Eraxis
Anidulafungin
- Strength / route
- 100mg · Intravenous infusion
- Qty
- 0 Vial
- Total
- 0
- Group
- N1
- Manufacturer
- Pharmacia & Upjohn Company LLC (United States)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN3-390-22 |
100mg
Intravenous infusion
|
Vial |
0
|
3,830,400
|
0
|
N1 |
Pharmacia & Upjohn Company LLC
United States
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Erbitux
Cetuximab
- Strength / route
- 5mg/ml · Intravenous infusion
- Qty
- 8,970 Vial
- Total
- 51,787,756,800
- Group
- N1
- Manufacturer
- Merck Healthcare KGaA (Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
QLSP-0708-13 |
5mg/ml
Intravenous infusion
|
Vial |
8,970
|
5,773,440
|
51,787,756,800
|
N1 |
Merck Healthcare KGaA
Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Espumisan L
Simethicon
- Strength / route
- 40mg/ml · Oral
- Qty
- 700 Vial
- Total
- 39,146,100
- Group
- N1
- Manufacturer
- Berlin Chemie AG (Germany)
- Province / Facility
- Hanoi · 01816
|
400100981824 |
40mg/ml
Oral
|
Vial |
700
|
55,923
|
39,146,100
|
N1 |
Berlin Chemie AG
Germany
|
Hanoi
01816
|
2026-04-14 |
|
Ethambutol 400mg
Ethambutol hydrochlorid
- Strength / route
- 400mg · Oral
- Qty
- 86,400 Tablet
- Total
- 136,080,000
- Group
- N3
- Manufacturer
- Imexpharm Corporation (Vietnam)
- Province / Facility
- Nghe An · 40018
|
893110437024 |
400mg
Oral
|
Tablet |
86,400
|
1,575
|
136,080,000
|
N3 |
Imexpharm Corporation
Vietnam
|
Nghe An
40018
|
2026-04-14 |
|
Exforge
Amlodipin + valsartan
- Strength / route
- 10mg + 160mg · Oral
- Qty
- 195,000 Tablet
- Total
- 3,530,865,000
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-16342-13 |
10mg + 160mg
Oral
|
Tablet |
195,000
|
18,107
|
3,530,865,000
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Exforge
Amlodipin + valsartan
- Strength / route
- 5mg + 80mg · Oral
- Qty
- 390,000 Tablet
- Total
- 3,894,930,000
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-16344-13 |
5mg + 80mg
Oral
|
Tablet |
390,000
|
9,987
|
3,894,930,000
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Exforge HCT 10mg/160mg/12.5mg
Amlodipin + valsartan + hydrochlorothiazid
- Strength / route
- 10mg + 12,5mg + 160mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19287-15 |
10mg + 12,5mg + 160mg
Oral
|
Tablet |
0
|
18,107
|
0
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Exforge HCT 10mg/160mg/12.5mg
Amlodipin + valsartan + hydrochlorothiazid
- Strength / route
- 10mg + 12,5mg + 160mg · Oral
- Qty
- 205,777 Tablet
- Total
- 3,726,004,139
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
840110032023 |
10mg + 12,5mg + 160mg
Oral
|
Tablet |
205,777
|
18,107
|
3,726,004,139
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Exforge HCT 5mg/160mg/12.5mg
Amlodipin + valsartan + hydrochlorothiazid
- Strength / route
- 5mg + 12,5mg + 160mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19289-15 |
5mg + 12,5mg + 160mg
Oral
|
Tablet |
0
|
18,107
|
0
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Exforge HCT 5mg/160mg/12.5mg
Amlodipin + valsartan + hydrochlorothiazid
- Strength / route
- 5mg + 12,5mg + 160mg · Oral
- Qty
- 156,494 Tablet
- Total
- 2,833,636,858
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
840110079223 |
5mg + 12,5mg + 160mg
Oral
|
Tablet |
156,494
|
18,107
|
2,833,636,858
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Fabamox 250
Amoxicilin
- Strength / route
- 250mg · Oral
- Qty
- 750 Sachet
- Total
- 1,575,000
- Group
- N3
- Manufacturer
- Central Pharmaceutical JSC No. 1 (Pharbaco) (Vietnam)
- Province / Facility
- Ninh Binh · 37315
|
VD-21362-14 |
250mg
Oral
|
Sachet |
750
|
2,100
|
1,575,000
|
N3 |
Central Pharmaceutical JSC No. 1 (Pharbaco)
Vietnam
|
Ninh Binh
37315
|
2026-04-14 |
|
Fabamox 250
Amoxicilin
- Strength / route
- 250mg · Oral
- Qty
- 600 Sachet
- Total
- 1,260,000
- Group
- N3
- Manufacturer
- Central Pharmaceutical JSC No. 1 (Pharbaco) (Vietnam)
- Province / Facility
- Ninh Binh · 37021
|
VD-21362-14 |
250mg
Oral
|
Sachet |
600
|
2,100
|
1,260,000
|
N3 |
Central Pharmaceutical JSC No. 1 (Pharbaco)
Vietnam
|
Ninh Binh
37021
|
2026-04-14 |
|
Faslodex
Fulvestrant
- Strength / route
- 50mg/ml · Injection
- Qty
- 799 Syringe
- Total
- 5,025,030,850
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vetter Pharma - Fertigung GmbH & Co.KG; Secondary packaging site: AstraZeneca UK Limited (Country of manufacture and primary packaging: Germany; Country of secondary packaging: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19561-16 |
50mg/ml
Injection
|
Syringe |
799
|
6,289,150
|
5,025,030,850
|
N1 |
Manufacturing and primary packaging site: Vetter Pharma - Fertigung GmbH & Co.KG; Secondary packaging site: AstraZeneca UK Limited
Country of manufacture and primary packaging: Germany; Country of secondary packaging: United Kingdom
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Fenilham
Fentanyl
- Strength / route
- 50mcg/ml · Injection
- Qty
- 1,600 Ampoule
- Total
- 45,528,000
- Group
- N1
- Manufacturer
- Siegfried Hameln GmbH (Germany)
- Province / Facility
- Quang Binh · 44008
|
VN-17888-14 |
50mcg/ml
Injection
|
Ampoule |
1,600
|
28,455
|
45,528,000
|
N1 |
Siegfried Hameln GmbH
Germany
|
Quang Binh
44008
|
2026-04-14 |
|
Fentanyl B. Braun
Fentanyl
- Strength / route
- 0,5mg/10ml · Injection
- Qty
- 6,000 Ampoule
- Total
- 252,000,000
- Group
- N1
- Manufacturer
- B.Braun Melsungen AG (Germany)
- Province / Facility
- Ha Giang · 02001
|
400111002124 |
0,5mg/10ml
Injection
|
Ampoule |
6,000
|
42,000
|
252,000,000
|
N1 |
B.Braun Melsungen AG
Germany
|
Ha Giang
02001
|
2026-04-14 |
|
Fentanyl B. Braun
Fentanyl
- Strength / route
- 0,5mg/10ml · Injection
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N1
- Manufacturer
- B.Braun Melsungen AG (Germany)
- Province / Facility
- Ha Giang · 02001
|
VN-21366-18 |
0,5mg/10ml
Injection
|
Ampoule |
0
|
42,000
|
0
|
N1 |
B.Braun Melsungen AG
Germany
|
Ha Giang
02001
|
2026-04-14 |
|
Firstlexin
Cephalexin
- Strength / route
- 250mg · Oral
- Qty
- 30,000 Sachet
- Total
- 84,420,000
- Group
- N3
- Manufacturer
- Pharbaco Central Pharmaceutical JSC No. 1 (Vietnam)
- Province / Facility
- Bac Ninh · 27002
|
VD-15813-11 |
250mg
Oral
|
Sachet |
30,000
|
2,814
|
84,420,000
|
N3 |
Pharbaco Central Pharmaceutical JSC No. 1
Vietnam
|
Bac Ninh
27002
|
2026-04-14 |
|
Firstlexin 500 DT.
Cefalexin
- Strength / route
- 500mg · Oral
- Qty
- 100,000 Tablet
- Total
- 300,000,000
- Group
- N4
- Manufacturer
- Central Pharmaceutical JSC No. 1 (Pharbaco) (Vietnam)
- Province / Facility
- Nghe An · 40018
|
893110270100 |
500mg
Oral
|
Tablet |
100,000
|
3,000
|
300,000,000
|
N4 |
Central Pharmaceutical JSC No. 1 (Pharbaco)
Vietnam
|
Nghe An
40018
|
2026-04-14 |
|
Flumetholon 0,1
Fluorometholon
- Strength / route
- 5mg/5ml · Ophthalmic
- Qty
- 500 Vial
- Total
- 16,086,000
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd. – Shiga Plant (Japan)
- Province / Facility
- Ha Giang · 02001
|
VN-18452-14 |
5mg/5ml
Ophthalmic
|
Vial |
500
|
32,172
|
16,086,000
|
N1 |
Santen Pharmaceutical Co., Ltd. – Shiga Plant
Japan
|
Ha Giang
02001
|
2026-04-14 |
|
Folina Tablets 15mg
Folinic acid
- Strength / route
- 15mg · Oral
- Qty
- 10,000 Tablet
- Total
- 83,000,000
- Group
- N2
- Manufacturer
- TTY Biopharm Co., Ltd. Lioudu Factory (Taiwan)
- Province / Facility
- Hanoi · 01916
|
VN-22797-21 |
15mg
Oral
|
Tablet |
10,000
|
8,300
|
83,000,000
|
N2 |
TTY Biopharm Co., Ltd. Lioudu Factory
Taiwan
|
Hanoi
01916
|
2026-04-14 |
|
Fortraget Inhaler 200mcg+6mcg
each dose hit contains Budesonide 200mcg + Formoterol fumarate dihydrate 6mcg
- Strength / route
- (200mcg+6mcg)/dose x 120 dose · Inhalation
- Qty
- 700 Canister
- Total
- 105,000,000
- Group
- N5
- Manufacturer
- Getz Pharma (Pvt) Ltd (Pakistan)
- Province / Facility
- Bac Ninh · 27002
|
VN-22022-19 |
(200mcg+6mcg)/dose x 120 dose
Inhalation
|
Canister |
700
|
150,000
|
105,000,000
|
N5 |
Getz Pharma (Pvt) Ltd
Pakistan
|
Bac Ninh
27002
|
2026-04-14 |
|
Forxiga
Dapagliflozin
- Strength / route
- 5mg · Oral
- Qty
- 15,535 Tablet
- Total
- 295,165,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN3-38-18 |
5mg
Oral
|
Tablet |
15,535
|
19,000
|
295,165,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 1,885,000 Tablet
- Total
- 35,815,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN3-37-18 |
10mg
Oral
|
Tablet |
1,885,000
|
19,000
|
35,815,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Fresofol 1% Mct/Lct
Propofol
- Strength / route
- 1% (10mg/ml) · Intravenous infusion
- Qty
- 25,000 Ampoule
- Total
- 875,000,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH (Austria)
- Province / Facility
- Hanoi · 01816
|
VN-17438-13 |
1% (10mg/ml)
Intravenous infusion
|
Ampoule |
25,000
|
35,000
|
875,000,000
|
N1 |
Fresenius Kabi Austria GmbH
Austria
|
Hanoi
01816
|
2026-04-14 |
|
GEL-APHOS
Aluminum phosphat
- Strength / route
- 12,38g gel (Aluminium phosphat 20%) · Oral
- Qty
- 4,169 Sachet
- Total
- 8,754,900
- Group
- N4
- Manufacturer
- CN Cty CPDP Agimexpharm - Nhà máy SX DP Agimexpharm (Vietnam)
- Province / Facility
- Da Nang · 48126
|
893110144824 |
12,38g gel (Aluminium phosphat 20%)
Oral
|
Sachet |
4,169
|
2,100
|
8,754,900
|
N4 |
CN Cty CPDP Agimexpharm - Nhà máy SX DP Agimexpharm
Vietnam
|
Da Nang
48126
|
2026-04-14 |
|
Galcholic 300
Ursodeoxycholic acid
- Strength / route
- 300mg · Oral
- Qty
- 50,000 Tablet
- Total
- 105,000,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01816
|
893110332223 |
300mg
Oral
|
Tablet |
50,000
|
2,100
|
105,000,000
|
N4 |
Hasan-Dermapharm Co., Ltd.
Vietnam
|
Hanoi
01816
|
2026-04-14 |
|
Galvus
Vildagliptin
- Strength / route
- 50mg · Oral
- Qty
- 26,260 Tablet
- Total
- 215,988,500
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
840110412723 |
50mg
Oral
|
Tablet |
26,260
|
8,225
|
215,988,500
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Galvus
Vildagliptin
- Strength / route
- 50mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19290-15 |
50mg
Oral
|
Tablet |
0
|
8,225
|
0
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Galvus Met 50mg/1000mg
Vildagliptin + metformin
- Strength / route
- 1000mg, 50mg · Oral
- Qty
- 394,641 Tablet
- Total
- 3,659,900,634
- Group
- N1
- Manufacturer
- Manufacturing site: Novartis Pharma Produktions GmbH; Packaging and batch release site: Lek Pharmaceuticals d.d., Poslovna enota PROIZVODNJA LENDAVA (Manufacturing site: Germany; Packaging and batch release site: Slovenia)
- Province / Facility
- Ho Chi Minh City · 79048
|
400110771824 |
1000mg, 50mg
Oral
|
Tablet |
394,641
|
9,274
|
3,659,900,634
|
N1 |
Manufacturing site: Novartis Pharma Produktions GmbH; Packaging and batch release site: Lek Pharmaceuticals d.d., Poslovna enota PROIZVODNJA LENDAVA
Manufacturing site: Germany; Packaging and batch release site: Slovenia
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Galvus Met 50mg/850mg
Vildagliptin + metformin
- Strength / route
- 850mg, 50mg · Oral
- Qty
- 65,650 Tablet
- Total
- 608,838,100
- Group
- N1
- Manufacturer
- Manufacturing site: Novartis Pharma Produktions GmbH; Packaging and batch release site: Lek Pharmaceuticals d.d., Poslovna enota PROIZVODNJA LENDAVA (Manufacturing site: Germany; Packaging and batch release site: Slovenia)
- Province / Facility
- Ho Chi Minh City · 79048
|
400110771924 |
850mg, 50mg
Oral
|
Tablet |
65,650
|
9,274
|
608,838,100
|
N1 |
Manufacturing site: Novartis Pharma Produktions GmbH; Packaging and batch release site: Lek Pharmaceuticals d.d., Poslovna enota PROIZVODNJA LENDAVA
Manufacturing site: Germany; Packaging and batch release site: Slovenia
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Garnotal 10
Phenobarbital
- Strength / route
- 10 mg · Oral
- Qty
- 10,000 Tablet
- Total
- 2,100,000
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01016
|
893112467324 |
10 mg
Oral
|
Tablet |
10,000
|
210
|
2,100,000
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Hanoi
01016
|
2026-04-14 |
|
Garnotal Inj
Phenobarbital
- Strength / route
- 200mg/2 ml · Injection
- Qty
- 40 Ampoule
- Total
- 504,000
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ba Ria – Vung Tau · 77001
|
VD-16785-12 |
200mg/2 ml
Injection
|
Ampoule |
40
|
12,600
|
504,000
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Ba Ria – Vung Tau
77001
|
2026-04-14 |
|
Geastine 250
Gefitinib
- Strength / route
- 250mg · Oral
- Qty
- 1,000 Tablet
- Total
- 48,800,000
- Group
- N4
- Manufacturer
- Minh Hai Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01816
|
893114115324 |
250mg
Oral
|
Tablet |
1,000
|
48,800
|
48,800,000
|
N4 |
Minh Hai Pharmaceutical JSC
Vietnam
|
Hanoi
01816
|
2026-04-14 |
